Karuna Kumar: Interesting Trial from Gambia on Treating Iron Deficiency in Children
Karuna Kumar, Senior Consultant at Yashoda Hospitals, shared a post on LinkedIn about a recent article by Mamadou Bah published in The American Journal of Clinical Nutrition, adding:
“Interesting trial from Gambia on treating iron deficiency in children.
The problem:
- Ferrous sulfate tablets work poorly in kids with chronic inflammation.
- Poor absorption.
- GI upset.
- Low compliance.
This study tested heme iron polypeptide (HIP) against standard ferrous salts.
Heme iron is the form found in meat.
It absorbs through a different pathway than regular iron supplements.
Doesn’t get blocked by inflammation the same way.
The results?
Both raised hemoglobin. But heme iron had better tolerability and absorption in kids with high inflammation markers.
Why this matters for India:
We have millions of children with chronic infections, parasites, and subclinical inflammation.
Standard iron tablets often fail them.
Heme iron supplements exist but are underused. They cost more, yes. But if regular iron isn’t working after 2-3 months, it’s worth considering.
Not every anemia responds to the cheapest option. Sometimes you need to match the treatment to the patient.”
Title: Heme iron compared with ferrous iron salts to treat iron deficiency anemia in Gambian children: a randomized controlled trial
Authors: Mamadou Bah, Hans Verhoef, Emmanuel Okoh, Abdoulie Bah, Alhasan Colley, Alasana Saidykhan, Andrew M Prentice, Carla Cerami
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026